Cvs Health Corp (CVS) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Cvs Health Corp (CVS) stock forecast summary
On Oct. 16, 2026, CVS is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
Cvs Health Corp is a large-cap company with a market capitalization of $118.13B. It ranks number 1 by market capitalization among the 5 Retail-Drug Stores and Proprietary Stores issuers in our coverage with a current forecast.
For CVS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 61.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 26.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CVS included.
Follow CVS freeCVS price chart and AI forecast
How CVS ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cvs Health Corp (CVS) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Retail-Drug Stores and Proprietary Stores peers listed below that report each metric.
Valuation & Market
| Metric | CVS | Rank |
|---|---|---|
| Market Cap | $118.13B | 1/5 |
| P/E Ratio | 24.37x | – |
| P/B Ratio | 1.48x | – |
| Dividend Yield | 2.89% | – |
| EPS | $3.79 | – |
| Book Value/Share | $62.32 | – |
| Revenue/Share | $324.55 | – |
| FCF/Share | $9.19 | – |
Profitability & Margins
| Metric | CVS | Rank |
|---|---|---|
| ROE | 6.1% | – |
| ROA | 1.9% | – |
| ROIC | 5.0% | – |
| Gross Margin | 44.5% | – |
| Operating Margin | 2.0% | – |
| Net Margin | 1.2% | – |
| EBT Margin | 1.4% | – |
| Tax Rate | 15.6% | – |
Financial Health
| Metric | CVS | Rank |
|---|---|---|
| Current Ratio | 0.87x | – |
| Quick Ratio | 0.66x | – |
| D/E Ratio | 2.18x | – |
| Financial Leverage | 3.18x | – |
| Interest Coverage | 3.0x | – |
| Working Capital | -$11.70B | – |
Cash Flow
| Metric | CVS | Rank |
|---|---|---|
| Operating Cash Flow | $14.78B | – |
| Free Cash Flow | $11.76B | – |
| Capital Spending | -$3.02B | – |
| OCF Growth YoY | 95.3% | – |
| FCF Growth YoY | 146.0% | – |
| FCF/Sales | 2.8% | – |
| CapEx/Sales | 0.7% | – |
Operational Efficiency
| Metric | CVS | Rank |
|---|---|---|
| Asset Turnover | 1.64x | – |
| Receivables Turnover | 10.3x | – |
| Inventory Turnover | 13.1x | – |
| Fixed Assets Turnover | 31.5x | – |
| Days Sales Outstanding | 35 days | – |
| Days Inventory | 28 days | – |
Income Statement
| Metric | CVS | Rank |
|---|---|---|
| Total Revenue | $415.09B | – |
| Operating Income | $8.29B | – |
| Net Income | $4.89B | – |
| Cost of Goods Sold | $230.41B | – |
Dividend & Shareholder Information
| Metric | CVS | Rank |
|---|---|---|
| Dividends Per Share | $2.67 | – |
| Payout Ratio | 70.5% | – |
| Shares Outstanding | 1279M | – |
| Net Income Growth | 7.9% | – |
| EPS Growth | -15.0% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $75.35B | 29.7% of assets |
| Cash & Short-term Investments | $11.33B | 4.5% of assets |
| Accounts Receivable | $40.31B | 15.9% of assets |
| Inventory | $17.62B | 6.9% of assets |
| Total Liabilities | $173.87B | 68.5% of assets |
CVS quarterly financials and insider trading
Cvs Health Corp (CVS) industry peers
Companies classified under the same SEC industry code as Cvs Health Corp (Retail-Drug Stores and Proprietary Stores): 5 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere CVS sits on the market map
Cvs Health Corp (CVS) stock news
Loading...
Cvs Health Corp (CVS) stock forecast FAQ
What is the Cvs Health Corp (CVS) stock forecast?
On Oct. 16, 2026, CVS is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Cvs Health Corp stock predictions?
For CVS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 61.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 26.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cvs Health Corp forecasts updated?
Cvs Health Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Cvs Health Corp's industry peers?
5 issuers in our coverage, CVS included, share the SEC industry code Retail-Drug Stores and Proprietary Stores. The largest are: Guardian Pharmacy Services, Inc. (GRDN), Trees Corp (Colorado) (CANN), Petmed Express Inc (PETS), Ridgetech Inc. (RDGT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.